loadpatents
Patent applications and USPTO patent grants for BURGER; Matthew T..The latest application filed is for "antibody drug conjugates for ablating hematopoietic stem cells".
Patent | Date |
---|---|
Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells App 20210228731 - BOITANO; Anthony Edward ;   et al. | 2021-07-29 |
Biaryl amide compounds as kinase inhibitors Grant 10,709,712 - Aversa , et al. | 2020-07-14 |
Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymerase Grant 10,604,547 - Burger , et al. | 2020-03-31 |
Amatoxin Derivatives And Conjugates Thereof As Inhibitors Of Rna Polymerase App 20200024311 - Burger; Matthew T. ;   et al. | 2020-01-23 |
Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymerase Grant 10,464,969 - Burger , et al. No | 2019-11-05 |
Compounds and compositions as kinase inhibitors Grant 10,392,404 - Barsanti , et al. A | 2019-08-27 |
Tricyclic compounds and compositions as kinase inhibitors Grant 10,377,770 - Aversa , et al. A | 2019-08-13 |
Biaryl Amide Compounds As Kinase Inhibitors App 20190175606 - AVERSA; Robert John ;   et al. | 2019-06-13 |
Amatoxin Derivatives And Conjugates Thereof As Inhibitors Of Rna Polymerase App 20190144504 - Burger; Matthew T. ;   et al. | 2019-05-16 |
Biaryl amide compounds as kinase inhibitors Grant 10,245,267 - Aversa , et al. | 2019-04-02 |
Compounds and compositions as RAF kinase inhibitors Grant 10,167,279 - Aversa , et al. J | 2019-01-01 |
Tricyclic Compounds And Compositions As Kinase Inhibitors App 20180362542 - AVERSA; Robert John ;   et al. | 2018-12-20 |
Compounds And Compositions As Raf Kinase Inhibitors App 20180170917 - AVERSA; Robert John ;   et al. | 2018-06-21 |
Compounds and compositions as kinase inhibitors Grant 9,809,610 - Burger , et al. November 7, 2 | 2017-11-07 |
Biaryl Amide Compounds As Kinase Inhibitors App 20170260207 - AVERSA; Robert John ;   et al. | 2017-09-14 |
Compounds And Compositions As Kinase Inhibitors App 20170260200 - BARSANTI; Paul Andrew ;   et al. | 2017-09-14 |
Compounds And Compositions As Kinase Inhibitors App 20170114083 - BURGER; Matthew T. ;   et al. | 2017-04-27 |
Compounds and compositions as kinase inhibitors Grant 9,573,969 - Burger , et al. February 21, 2 | 2017-02-21 |
Compounds And Compositions As Kinase Inhibitors App 20160075727 - Burger; Matthew T. ;   et al. | 2016-03-17 |
Biaryl Amide Compounds As Kinase Inhibitors App 20160038504 - AVERSA; Robert John ;   et al. | 2016-02-11 |
Kinase Inhibitors And Methods Of Their Use App 20150315150 - Burger; Matthew T. ;   et al. | 2015-11-05 |
Kinase inhibitors and methods of their use Grant 9,079,889 - Burger , et al. July 14, 2 | 2015-07-14 |
Kinase Inhibitors And Methods Of Their Use App 20140079693 - Burger; Matthew T. ;   et al. | 2014-03-20 |
Kinase inhibitors and methods of their use Grant 8,592,455 - Burger , et al. November 26, 2 | 2013-11-26 |
Kinase inhibitors and methods of their use Grant 8,329,732 - Burger , et al. December 11, 2 | 2012-12-11 |
Kinase Inhibitors And Methods Of Their Use App 20120134987 - Burger; Matthew T. ;   et al. | 2012-05-31 |
Kinase inhibitors and methods of their use App 20100056576 - BURGER; Matthew T. ;   et al. | 2010-03-04 |
Heteroaryl-fused Pyrimidinyl Compounds As Anticancer Agents App 20080069817 - Wang; Weibo ;   et al. | 2008-03-20 |
Heteroaryl-fused pyrimidinyl compounds as anticancer agents Grant 7,345,046 - Wang , et al. March 18, 2 | 2008-03-18 |
Pyridyl substituted ketolide antibiotics Grant 7,332,476 - Burger , et al. February 19, 2 | 2008-02-19 |
Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents Grant 7,326,711 - Wang , et al. February 5, 2 | 2008-02-05 |
Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents App 20050085490 - Wang, Weibo ;   et al. | 2005-04-21 |
Heteroaryl-fused pyrimidinyl compounds as anticancer agents App 20050065169 - Wang, Weibo ;   et al. | 2005-03-24 |
Pyridyl substituted ketolide antibiotics App 20050009764 - Burger, Matthew T. ;   et al. | 2005-01-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.